Procter & Gamble will acquire supplements brand Thorne for $3.8 billion, CEO tells CNBC

Procter & Gamble has entered into a definitive agreement to acquire Thorne, a company specializing in the production of supplements. This strategic move signals a significant investment by the consumer goods giant into the supplement sector. The deal was formally announced via a definitive agreement, establishing the framework for the transfer of ownership from Thorne to P&G. The announcement has received widespread attention from major financial and business news outlets. According to reports from CNBC, P&G CEO Jejurikar personally disclosed the details of the acquisition during an interview with the network.

This information was further corroborated and detailed by Bloomberg.com and the Wall Street Journal, both of which highlighted the $3.8 billion price tag. Additionally, PR Newswire distributed the official notice regarding the definitive agreement, while Reuters reported on the CEO's statements provided to CNBC. Contextually, this acquisition represents a multi-billion dollar entry or expansion for Procter & Gamble into the specialized supplements market. By targeting Thorne, P&G is integrating a brand focused on supplements into its broader corporate structure. The scale of the $3.8 billion investment underscores the perceived value of Thorne's market position and the strategic importance P&G places on health-oriented product lines.

Looking forward, the transition will depend on the completion of the terms set forth in the definitive agreement. Observers will be watching for the finalization of the $3.8 billion transaction and how P&G intends to integrate the Thorne brand into its existing portfolio of consumer goods. While the CEO has confirmed the intent and the price to CNBC, further details regarding the operational integration of the supplements maker will likely emerge as the acquisition process moves toward its closing phase.